🇬🇧·1d agoResearch
GLP-1 receptor agonist targets an AMPKα1-HIF1α-PFKFB3 metabolic vulnerability and enhances Lenvatinib response in hepatocellular carcinoma
Publisher
n
npj Precision Oncology
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- npj Precision Oncology
- Region
- UK
- Scope
- Research
- Published
- June 29, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on nature.com
Leave the platform to read the original full article on the publisher site.
Source: npj Precision Oncology
Scope: Research
Related coverage
More related coverage
Universitätsspital Zürich (USZ)/1h ago
Regina Gerdes verlässt das Universitätsspital Zürich
UNMC/2h ago
UNMC to host America 250 event today
Policlinico di Milano/4h ago
#NUTRICETTE. Insalata estiva di ceci, cetriolo, avocado e menta
Hospital Clínic de Barcelona/4h ago